MALT lymphomas: a radiation oncology viewpoint.
Yahalom
J
J
Memorial Sloan-Kettering Cancer Center, Cornell University, New York, NY 10021, USA. yahalom@mskcc.org
D000328:Adult; D000368:Aged; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D005260:Female; D005743:Gastrectomy; D005756:Gastritis / Q000150:complications / Q000188:drug therapy; D016481:Helicobacter Infections / Q000150:complications / Q000188:drug therapy; D016480:Helicobacter pylori / Q000472:pathogenicity; D006801:Humans; D008175:Lung Neoplasms / Q000453:epidemiology / Q000628:therapy; D018442:Lymphoma, B-Cell, Marginal Zone / Q000145:classification / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D008228:Lymphoma, Non-Hodgkin / Q000401:mortality / Q000473:pathology / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D011836:Radiation Tolerance; D012074:Remission Induction; D013274:Stomach Neoplasms / Q000145:classification / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000628:therapy; D016896:Treatment Outcome